Zura Bio (ZURA) Enterprise Value (2021 - 2026)
Zura Bio (ZURA) posted quarterly Enterprise Value of -$225.6 million for Q1 2026, down 33.44% year-over-year from -$338.9 million in Q1 2025, and down 106.2% quarter-over-quarter from -$109.4 million in Q4 2025.
Zura Bio (ZURA) Enterprise Value (2021 - 2026) Analysis & Trends
Zura Bio's Enterprise Value history runs 6 years deep, the most recent figure standing at -$225.6 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 33.44% year-over-year to -$225.6 million; the TTM figure through Mar 2026 stood at -$225.6 million (down 33.44% YoY), while the FY2025 annual figure was -$109.4 million, up 31.21% from the prior year.
- Enterprise Value for Q1 2026 stood at -$225.6 million, down from -$109.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.6 million in Q4 2022, with the low at -$225.6 million in Q1 2026.
- The 5-year median for Enterprise Value is -$109.4 million (2025), against an average of -$103.6 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value slumped 5075.88% in 2023, then soared 31.21% in 2025.
- Zura Bio's Enterprise Value stood at -$1.6 million in 2022, then plunged by 5075.88% to -$81.1 million in 2023, then tumbled by 96.09% to -$159.0 million in 2024, then jumped by 31.21% to -$109.4 million in 2025, then tumbled by 106.2% to -$225.6 million in 2026.
- Business Quant data shows ZURA's Enterprise Value at -$225.6 million in Q1 2026, -$109.4 million in Q4 2025, and -$130.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Zura Bio | 706.30 Mn | 706.30 Mn | - | -205.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -205.13 Mn |
| Mar 31, 2026 | -225.59 Mn |
| Dec 31, 2025 | -109.41 Mn |
| Sep 30, 2025 | -130.34 Mn |
| Jun 30, 2025 | -152.96 Mn |
| Mar 31, 2025 | -169.06 Mn |
| Dec 31, 2024 | -159.04 Mn |
| Sep 30, 2024 | -186.68 Mn |
| Jun 30, 2024 | -186.90 Mn |
| Mar 31, 2024 | -88.28 Mn |
| Dec 31, 2023 | -81.11 Mn |
| Sep 30, 2023 | -102.32 Mn |
| Jun 30, 2023 | -111.26 Mn |
| Mar 31, 2023 | -43.96 Mn |
| Dec 31, 2022 | -1.57 Mn |
| Sep 30, 2022 | -3.05 Mn |
| Jun 30, 2022 | -4.41 Mn |
| Mar 31, 2022 | -4.72 Mn |
| Dec 31, 2021 | -729,223.00 |